Edition:
United Kingdom

People: Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

22.93USD
23 Aug 2019
Change (% chg)

$-1.06 (-4.42%)
Prev Close
$23.99
Open
$23.80
Day's High
$24.25
Day's Low
$22.81
Volume
194,119
Avg. Vol
247,579
52-wk High
$27.50
52-wk Low
$12.20

Chalmers, Derek 

Dr. Derek Chalmers, Ph.D. serves as a President, Chief Executive Officer and a Director at Cara Therapeutics, Inc. Dr. Chalmers has over 25 years’ experience in the biotechnology industry with increasing levels of corporate and business responsibilities. Prior to founding Cara, Dr. Chalmers co-founded Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a drug discovery and development company, and served as its Vice President and Executive Director from June 1997 until May 2004. Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on our Board of Directors include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry, including having been a founder of a prior biotechnology company.

Basic Compensation

Total Annual Compensation, USD 780,624
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,008,420
Fiscal Year Total, USD 2,789,050

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Derek Chalmers

2,789,050

Mani Mohindru

4,046,470

Frederique Menzaghi

1,238,230

Scott Terrillion

--

Joana Goncalves

3,736,190

Martin Vogelbaum

332,261
As Of  31 Dec 2018